Cardiac Shock Flashcards

1
Q

define heart failure and the two types

A

HF- clinical syndrome resulting from impairment of ventricular filing or ejection

forward- too little blood leaves heart

backward- blood accumulates behind heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

symptoms of heart failure

A

edema, dyspnea, SOB, paroxysmal nocturnal dyspnea, fatigue, exercise intolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

most common cuase of heart failure

A

myocardial disorders leading to ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

etiology of heart failure types

most common?

A

ischemic, hypertensive, valvular, rheumatic fever, congenital heart disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

systolic v diastolic heart failure

A

diastolic- impaired filling (backwards)
LVEF greater than 50
concentric hypertrophy

systolic- impaired ejection (forward)
LVEF less than 40
eccentric hypertrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how does systolic dysfunction effect the stalring curve?

A

refer to notes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

draw a pressure-volume loop. how is it affected by changes to preload, afterload, and contractility?

A

refer to notes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

characterization of heart disease severity

A
NYHA-
1 no limitations
2 slight limitations
3 marked limitations
4 cannot do physical activity
American College of Cardiology
A- at high risk
B- structural disease w/o symptoms
C- strutural disease w/ history of symptoms
D- HF despite therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe the hemodynamic profiles and how they provide a guideline for treatment

A

refer to notes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

neurohormonal responses to heart failure

A

short term- cardiac stimulation via B1-adrenergics, vasoconstriction, water retention, Na retention

long term- neurohormones, cytoskeleton signaling, cytokines, epigentics

helpful in short term but harmful long term

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

energy starvation causes and consequences

A

causes- increased myocyte demand, decreased energy supply, decreased energy release from ATP

consequences- impaired contractility, impaired membrane ion pump function, myocyte death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

therapy w/ signs/symptoms of heart congestion

A

low Na diet
fluid restriction
diuretics (loop- Na/K/2Cl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

therapies for diastolic HF

A

none

manage comorbidities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

therapies for systolic HF

A

ACE-I, B-blockers, aldosterone antagonists, digoxin, inotropes, ARBs, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ACE inhibitors

A

Ag2 causes increased Na, aldosterone, and vasoconstriction

ACE inhibitors prevent conversion of Ag1 to active Ag2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ARBs

A

block effects of Ag2 at receptor

Ag2 causes increased Na, aldosterone, and vasoconstriction

indicated when pts dont tolerate ACE-I

17
Q

aldosterone antagonists

A

spironolacrone- lots of off target effects- gynecomastia, breast pain, impotence

eplenerone- blocks mineral corticoid receptor

used in conjunction w/ ACE-I to prevent aldosterone escape

18
Q

B- blockers

A

sympathetic activation correlates w/ heart disease severity

block sympathetic activation of heart

19
Q

valsartan/sacubitril

A

used in place of ACE-I or ARB

valsartan is ARB

sacubitril is a neprilysin inhibitor- blocks degradation of ANP and BNP

20
Q

comination of isosorbide/hydralazine

A

used for african americans

21
Q

digoxin

A

cardiac glycoside
blocks Na/ K ATPase, increasing intracellular Na and contractility

no mortality benefits

22
Q

irabradine

A

blocks If channel in nodes, slowing HR

no mortality benefits

23
Q

inotropes

A

milrinone, dobutamine

increase contractility, but increase mortality

used as bridge or palliative care

24
Q

two types of implantable devices

A

ICD- monitors for abnormal heart rhythm- can be used for primary or secondary prevention

CRT- indicated w/ HF and wide QRS on EKG. can also contain ICD

25
Q

classificaiton system for advanced cardiac disease

A

INTERMACs

26
Q

presentation of advanced cardiac disease

A

tachycardia, hypotensive, dypnic, cold skin

labs- acidosis, increase lactate and liver enzymes

RH catheterization

27
Q

medical management of advanced heart failure

A

diuretics, vasodilators, digoxins, ionotropic agents, revascularization, increase HR

28
Q

mechanical management of advanced heart failure

A

temporary- intra-aortic balloon pump, impella, tandem heart, ECMO

durable mechanical support- LVAD, TAH

heart transplant